A good pathologist can be a gastroenterologist’s best friend. A good GI pathologist, that is.
While the need for advanced endoscopic training programs is expected to grow, various issues are yet to be resolved, such as accreditation, assessment and curriculum.
Current treatments for hepatitis C virus (HCV) are quite effective, with a cure rate inching toward 100 percent. However, there are certain subpopulations that fail direct-acting antiviral (DAA) therapy and others who have yet to be diagnosed — up to 50 percent of people with the virus, according to some estimates.
Until the advent of corticosteroids and colectomy, nearly a third of inpatients with ulcerative colitis died of their disease. Even with effective treatments available, challenges remain in the medical and surgical management of these patients.
This year’s ASGE Postgraduate Course will bring together an outstanding faculty of internationally renowned experts who will share tips for perfecting various endoscopic procedures and incorporating new modalities into clinical practice.
Burnout is more than growing tired of doing the same thing over and over. It’s a state of emotional exhaustion that results in depersonalized interactions with patients, colleagues, family and friends, according to Arthur DeCross, MD, professor of medicine at the University of Rochester Medical Center, NY.
Now in its fourth year, the ASGE International Program at DDW® features seven joint symposia with international organizations from Korea, Latin America, India, Australia, Japan, China and Brazil.
Changes in colorectal cancer (CRC) screening guidelines have left many clinicians wondering what the best option is. On Tuesday, AGA is staging a ‘cage match’ session that will pit top experts in the field against one another to help DDW® attendees judge for themselves.
Growing evidence suggests that pancreatic neuroendocrine tumors (PNET) are more common than previously thought. Four experts will discuss the latest data during Sunday’s DDW Clinical Symposium Recent Advances in Neuroendocrine Tumors of the Pancreas, which is jointly sponsored by AGA and SSAT.
International experts will discuss different approaches to IBD during pregnancy, and how recent data may affect treatment decisions during Sunday’s AGA Clinical Symposium The Pregnant Patient with IBD: Data for an International Consensus?!
